Financhill
Sell
25

ADAP Quote, Financials, Valuation and Earnings

Last price:
$0.28
Seasonality move :
1.92%
Day range:
$0.25 - $0.31
52-week range:
$0.20 - $1.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.36x
P/B ratio:
5.43x
Volume:
19.4M
Avg. volume:
2M
1-year change:
-78.63%
Market cap:
$64.3M
Revenue:
$178M
EPS (TTM):
-$0.31

Adaptimmune Therapeutics PLC SEC Filings

Company Filed Form Type Description
ADAP
Adaptimmune Therapeutics PLC
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
08/09/2023 10-Q 10-Q filing on 08/09/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
05/12/2023 10-Q 10-Q filing on 05/12/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
11/08/2022 10-Q 10-Q filing on 11/08/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
05/09/2022 10-Q 10-Q filing on 05/09/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
11/04/2021 10-Q 10-Q filing on 11/04/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
08/09/2021 10-Q 10-Q filing on 08/09/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
05/06/2021 10-Q 10-Q filing on 05/06/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
08/06/2020 10-Q 10-Q filing on 08/06/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
05/28/2020 10-Q 10-Q filing on 05/28/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
05/14/2020 10-Q 10-Q filing on 05/14/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
02/27/2020 10-K 10-K filing on 02/27/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
11/06/2019 10-Q 10-Q filing on 11/06/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
08/01/2019 10-Q 10-Q filing on 08/01/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
05/06/2019 10-Q 10-Q filing on 05/06/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
02/27/2019 10-K 10-K filing on 02/27/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
11/06/2018 10-Q 10-Q filing on 11/06/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
08/02/2018 10-Q 10-Q filing on 08/02/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
03/15/2018 10-K 10-K filing on 03/15/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
11/02/2017 10-Q 10-Q filing on 11/02/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
08/03/2017 10-Q 10-Q filing on 08/03/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
05/10/2017 10-Q 10-Q filing on 05/10/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
04/06/2017 10-Q 10-Q filing on 04/06/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
03/13/2017 10-K 10-K filing on 03/13/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
11/10/2016 10-Q 10-Q filing on 11/10/2016 View Form
ADAP
Adaptimmune Therapeutics PLC
08/08/2016 10-Q 10-Q filing on 08/08/2016 View Form
ADAP
Adaptimmune Therapeutics PLC
05/12/2016 10-Q 10-Q filing on 05/12/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 7.27% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 5.38% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 0.6% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock